# The Efficacy and Safety of the Xue-Fu-Zhu-Yu Capsule in Treatment of Qi Stagnation and Blood Stasis Syndrome.

> **NCT03091634** · PHASE2 · COMPLETED · sponsor: **Guang'anmen Hospital of China Academy of Chinese Medical Sciences** · enrollment: 120 (actual)

## Conditions studied

- Qi Stagnation and Blood Stasis Syndrome

## Interventions

- **DRUG:** xue-fu-zhu-yu capsule
- **DRUG:** xue-fu-zhu-yu capsule simulated agent

## Key facts

- **NCT ID:** NCT03091634
- **Lead sponsor:** Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-06
- **Primary completion:** 2018-10-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2019-11-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03091634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03091634, "The Efficacy and Safety of the Xue-Fu-Zhu-Yu Capsule in Treatment of Qi Stagnation and Blood Stasis Syndrome.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03091634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*